ITeos Therapeutics Inc logo

ITeos Therapeutics Inc

$ 23.33 -1.55 (-6.23%) 11:09 PM EST
P/E:
2.73
P/B:
1.32
Market Cap:
$ 829.97M
Enterprise V:
$ 98.06M
Volume:
342.84K
Avg Vol (2M):
429.09K
Volume:
342.84K
Market Cap $:
829.97M
PE Ratio:
2.73
Avg Vol (2-Month):
429.09K
Enterprise Value $:
98.06M
PB Ratio:
1.32
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

ITeos Therapeutics Inc
NAICS : 541714 SIC : 2833
321 Arsenal Street, Watertown, MA, USA, 02472
Description
ITeos Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of immuno-oncology therapeutics for patients. Its product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody.
Name Current Vs Industry Vs History
Cash-To-Debt 164.73
Equity-to-Asset 0.78
Debt-to-Equity 0.01
Debt-to-EBITDA 0.01
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 7/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 6.74
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 29.91
9-Day RSI 38.65
14-Day RSI 44.12
6-1 Month Momentum % -26.54
12-1 Month Momentum % 0.2

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.42
Quick Ratio 6.42
Cash Ratio 6.31

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -67.8

Financials (Next Earnings Date:2022-11-10 Est.)

ITOS's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:ITOS

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 539.013
EPS (TTM) ($) 8.72
Beta 0
Volatility % 74.16
14-Day RSI 44.12
14-Day ATR ($) 1.661397
20-Day SMA ($) 25.455
12-1 Month Momentum % 0.2
52-Week Range ($) 16.21 - 52.43
Shares Outstanding (Mil) 35.58

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

ITeos Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More